Germany · 
Who invested in CEVEC Pharmaceuticals?
CEVEC Pharmaceuticals's investors include KfW, Creathor Ventures and nrw.bank.
20102011
$5.4MSeries B$8.6MVentureGermany · Venture startup
Who invested in CEVEC Pharmaceuticals
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow CEVEC Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$14Mraised across 2 rounds since 2010, from 2 sources
$5.4MSeries B$8.6MVenture
- Latest round
- Venture, $8.6MJul 2011
- Step-upi
- 1.6×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $5.4M Feb 2010
- Biggest round
- $8.6M Venture · Jul 2011
- Between rounds
- 18 months from the last two
The rounds
- Jul 2011
- Feb 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about CEVEC Pharmaceuticals
How much has CEVEC Pharmaceuticals raised?
CEVEC Pharmaceuticals has raised $14M across 2 rounds since 2010.
When did CEVEC Pharmaceuticals last raise?
CEVEC Pharmaceuticals's most recent round was a Venture of $8.6M in Jul 2011.
What was CEVEC Pharmaceuticals's biggest round?
Its most recent round, $8.6M in Jul 2011, is also its largest on record.
Who backed CEVEC Pharmaceuticals first?
CEVEC Pharmaceuticals's first round on record, in Feb 2010, was backed by KfW, Creathor Ventures and nrw.bank.
What stage is CEVEC Pharmaceuticals at?
CEVEC Pharmaceuticals's latest named round is a Venture, in Jul 2011.
Where is CEVEC Pharmaceuticals based?
CEVEC Pharmaceuticals is based in Germany.
Companies like CEVEC Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.